Lawrence Richer

Professor and Vice-Dean Research (clinical)

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lawrence Richer is a Professor and Vice-Dean Research (Clinical) at the University of Alberta in Canada. His research focuses on healthcare costs associated with neurological conditions such as multiple sclerosis and migraine, as well as post-stroke care. Recent articles include studies on the economic impact of disability levels in multiple sclerosis and the effects of treatment pathways on patient outcomes.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Daniel Tsze

Associate Professor of Pediatrics in Emergency Medicine at CUMC

Columbia University

UNITED STATES

View details

Jennifer McCombe

Associate Professor

University of Alberta

CANADA

View details

Peter Seres

University of Alberta

CANADA

View details

Merlin Butler

Professor

University of Kansas Medical Center

UNITED STATES

View details

Thilinie Rajapakse

Pediatric Neurologist, Associate Professor

University of Alberta

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lawrence Richer

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

The Healthcare Cost of Migraine: A Retrospective Cohort Study from Alberta, Canada

Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta

Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta

Geographical Variation In Medication and Health Resource Use In Multiple Sclerosis

Poststroke Care Pathways and Spasticity Treatment: A Retrospective Study in Alberta

Effect of lower body negative pressure on cardiac and cerebral function in postural orthostatic tachycardia syndrome: A pilot MRI assessment

Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

Disease-modifying therapy use and health resource utilisation associated with multiple sclerosis over time: A retrospective cohort study from Alberta, Canada

Effect of lower body negative pressure on cardiac and cerebral function in postural orthostatic tachycardia syndrome: A pilot MRI assessment

Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition

Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader–Willi Syndrome

Trajectory of health care resources among adults stopping or reducing treatment frequency of botulinum toxin for chronic migraine treatment in Alberta, Canada

Stratification of risk for emergent intracranial abnormalities in children with headaches: a Pediatric Emergency Care Applied Research Network (PECARN) study protocol

A randomized trial of ketorolac and metoclopramide for migraine in the emergency department

Interobserver Agreement in the Assessment of Clinical Findings in Children with Headaches

Study protocol for two complementary trials of non-steroidal or opioid analgesia use for children aged 6 to 17 years with musculoskeletal injuries (the No OUCH study)

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance

Efficacy of melatonin in children with postconcussive symptoms: A randomized clinical trial

Collaborators (5)

Daniel Tsze

Jennifer McCombe

Peter Seres

Merlin Butler

Thilinie Rajapakse

Make your next move.